Caprock Group, Inc. Bristol Myers Squibb CO Transaction History

Caprock Group, Inc.

$3.21 Billion
Q1 2025

A detailed history of Caprock Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Caprock Group, Inc. holds 77,386 shares of BMY stock, worth $3.87 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

77,386

Previous 78,433 1.33%

Holding current value

$3.87 Million

Previous $4.44 Million 6.38%

% of portfolio

0.15%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$53.9 - $63.11 $56,433 - $66,076	-1,047 Reduced 1.33%	77,386 $4.72 Million
Q4 2024 Jan 23, 2025	BUY	$51.92 - $59.94 $923,968 - $1.07 Million	17,796 Added 29.35%	78,433 $4.44 Million
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $629,404 - $821,272	15,870 Added 35.45%	60,637 $3.14 Million
Q2 2024 Aug 06, 2024	BUY	$40.25 - $52.99 $646,777 - $851,496	16,069 Added 55.99%	44,767 $1.86 Million
Q1 2024 Apr 29, 2024	BUY	$47.98 - $54.4 $194,942 - $221,027	4,063 Added 16.49%	28,698 $1.56 Million
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $215,832 - $257,548	-4,452 Reduced 15.31%	24,635 $1.26 Million
Q3 2023 Oct 18, 2023	SELL	$57.89 - $64.73 $202,093 - $225,972	-3,491 Reduced 10.72%	29,087 $1.69 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $138,632 - $153,930	2,176 Added 7.16%	32,578 $2.08 Million
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $221,639 - $251,389	-3,373 Reduced 9.99%	30,402 $2.11 Million
Q4 2022 Jan 23, 2023	BUY	$68.48 - $81.09 $28,008 - $33,165	409 Added 1.23%	33,775 $0
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $86 - $51,329	668 Added 2.04%	33,366 $2.37 Million
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $20,333 - $22,394	280 Added 0.86%	32,698 $2.54 Million
Q1 2022 Apr 12, 2022	BUY	$61.48 - $73.72 $340,906 - $408,777	5,545 Added 20.63%	32,418 $2.39 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $191,512 - $223,258	-3,571 Reduced 11.73%	26,873 $1.68 Million
Q3 2021 Oct 07, 2021	SELL	$59.17 - $69.31 $262,300 - $307,251	-4,433 Reduced 12.71%	30,444 $1.82 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $432,441 - $470,928	6,985 Added 25.04%	34,877 $2.33 Million
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $228,459 - $256,948	-3,850 Reduced 12.13%	27,892 $1.77 Million
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $130,954 - $148,395	2,268 Added 7.69%	31,742 $1.99 Million
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $184,867 - $204,857	3,219 Added 12.26%	29,474 $1.78 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $135,295 - $158,174	2,468 Added 10.38%	26,255 $1.54 Million
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $119,248 - $173,295	-2,570 Reduced 9.75%	23,787 $1.33 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $222,429 - $290,138	4,520 Added 20.7%	26,357 $1.69 Million
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $44,865 - $53,194	-1,049 Reduced 4.58%	21,837 $1.11 Million
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $18,428 - $20,377	-413 Reduced 1.77%	22,886 $1.04 Million
Q1 2019 Apr 12, 2019	BUY	$45.12 - $53.8 $17,732 - $21,143	393 Added 1.72%	23,299 $1.11 Million
Q4 2018 Jan 29, 2019	BUY	$48.76 - $63.23 $117,609 - $152,510	2,412 Added 11.77%	22,906 $1.19 Million
Q3 2018 Oct 17, 2018	SELL	$55.19 - $62.25 $1,158 - $1,307	-21 Reduced 0.1%	20,494 $1.27 Million
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $146,233 - $182,264	-2,894 Reduced 12.36%	20,515 $1.14 Million
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $2,576 - $2,966	43 Added 0.18%	23,409 $1.48 Million
Q4 2017 Jan 17, 2018	SELL	$59.94 - $65.35 $79,480 - $86,654	-1,326 Reduced 5.37%	23,366 $1.48 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $1.36 Million - $1.57 Million	24,692	24,692 $1.57 Million

Others Institutions Holding BMY

# of Institutions

2,811

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $106B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Bristol Myers Squibb CO Transaction History